Lee, J., Im, S., Kim, G. M., Jung, K. H., Kang, S. Y., Park, I. H., . . . Park, Y. H. (2021). Implications of Tamoxifen Resistance in Palbociclib Efficacy for Patients with Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer: Subgroup Analyses of KCSG-BR15-10 (YoungPEARL). Cancer Res Treat.
Citação norma ChicagoLee, Jiyun, Seock-Ah Im, Gun Min Kim, Kyung Hae Jung, Seok Yun Kang, In Hae Park, Jee Hyun Kim, Hee Kyung Ahn, and Yeon Hee Park. "Implications of Tamoxifen Resistance in Palbociclib Efficacy for Patients With Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer: Subgroup Analyses of KCSG-BR15-10 (YoungPEARL)." Cancer Res Treat 2021.
Deismireacht MLALee, Jiyun, et al. "Implications of Tamoxifen Resistance in Palbociclib Efficacy for Patients With Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer: Subgroup Analyses of KCSG-BR15-10 (YoungPEARL)." Cancer Res Treat 2021.